Mechanisms of Vasorelaxation Induced by Hexahydrocurcuminin Isolated Rat Thoracic Aorta

Phytotherapy Research

Volumn 29, Issue 11, 2015, Pages 1806-1813

  Moohammadaree, Aida ^a   Changtam, Chatchawan ^b   Wicha, Piyawadee ^a   Suksamrarn, Apichart ^c   Tocharus, Jiraporn ^a   Tocharus, Chainarong ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b HUACHIEW CHALERMPRAKIET UNIVERSITY   (Thailand)

^c RAMKHAMHAENG UNIVERSITY   (Thailand)

Author keywords

aorta; endothelium independent; hexahydrocurcumin (HHC); hypertension; vasorelaxation

Indexed keywords

BETA ADRENERGIC RECEPTOR; CAFFEINE; CALCIUM CHLORIDE; CALCIUM ION; ENZYME ACTIVATOR; HEXAHYDROCURCUMIN; PHENYLEPHRINE; PHOBAL 12 MYRISTATE 13 ACETATE; POTASSIUM CHLORIDE; PROPRANOLOL; PROTEIN KINASE C; UNCLASSIFIED DRUG; VASODILATOR AGENT; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CURCUMA LONGA; DRUG MECHANISM; DRUG STRUCTURE; EC50; ENDOTHELIUM; EXTRACELLULAR CALCIUM; ISOLATED ARTERY; MALE; NONHUMAN; RAT; THORACIC AORTA; VASCULAR RING; VASOCONSTRICTION; VASODILATATION; ANIMAL; CURCUMA; DRUG EFFECTS; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, THORACIC; CURCUMA; ENDOTHELIUM, VASCULAR; MALE; RATS; VASODILATION; VASODILATOR AGENTS;

EID: 84946489162     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5448     Document Type: Article

References (37)

1. Adaramoye OA, Anjos RM, Almeida MM, et al,. 2009. Hypotensive and endothelium-independent vasorelaxant effects of methanolic extract from Curcuma longa L. in rats. J Ethnopharmacol 124: 457-462.
2. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB,. 2007. Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818.
3. Belviranli M, Okudan N, Atalik KE, Oz M,. 2013. Curcumin improves spatial memory and decreases oxidative damage in aged female rats. Biogerontology 14: 187-196.
4. Berridge MJ, Bootman MD, Roderick HL,. 2003. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517-529.
5. Bhullar KS, Jha A, Youssef D, Rupasinghe HP,. 2013. Curcumin and its carbocyclic analogs: structure-activity in relation to antioxidant and selected biological properties. Molecules 18; 5389-5404.
6. Brito TS, Lima FJ, Aragao KS, et al,. 2013. The vasorelaxant effects of 1-nitro-2-phenylethane involve stimulation of the soluble guanylate cyclase-cGMP pathway. Biochem Pharmacol 85: 780-788.
7. Changtam C, de Koning HP, Ibrahim H, Sajid MS, Gould MK, Suksamrarn A,. 2010. Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. Eur J Med Chem 45: 941-956.
8. Chen GP, Ye Y, Li L, Yang Y, Qian AB, Hu SJ, 2009. Endothelium-independent vasorelaxant effect of sodium ferulate on rat thoracic aorta. Life Sci 84: 81-88.
9. Dempe JS, Scheerle RK, Pfeiffer E, Metzler M,. 2013. Metabolism and permeability of curcumin in cultured Caco-2 cells. Mol Nutr Food Res 57: 1543-1549.
10. Deters M, Knochenwefel H, Lindhorst D, et al,. 2008. Different curcuminoids inhibit T-lymphocyte proliferation independently of their radical scavenging activities. Pharm Res 25: 1822-1827.
11. Dulbecco P, Savarino V,. 2013. Therapeutic potential of curcumin in digestive diseases. World J Gastroenterol 19: 9256-9270.
12. Hilgers RH, Webb RC,. 2005. Molecular aspects of arterial smooth muscle contraction: focus on Rho. Exp Biol Med 230: 829-835.
13. Hlavackova L, Janegova A, Ulicna O, Janega P, Cerna A, Babal P,. 2011. Spice up the hypertension diet-curcumin and piperine prevent remodeling of aorta in experimental L-NAME induced hypertension. Nutr Metab 8: 1743-7075.
14. Holder GM, Plummer JL, Ryan AJ,. 1978. The metabolism and excretion of curcumin [1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] in the rat. Xenobiotica 8: 761-768.
15. Huang Y, Kwok KH,. 1998. Beta-adrenoceptor-mediated relaxation inhibited by tetrapentylammonium ions in rat mesenteric artery. Life Sci 62: L19-25.
16. Ireson C, Orr S, Jones DJ, et al,. 2001. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61: 1058-1064.
17. Ireson CR, Jones DJ, Orr S, et al,. 2002. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11: 105-111.
18. Ishida J, Ohtsu H, Tachibana Y, et al,. 2002. Antitumor agents. Part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents. Bioorg Med Chem 10: 3481-3487.
19. Jackson WF,. 2000. Ion channels and vascular tone. Hypertension 35: 173-178.
20. Lee SL, Huang WJ, Lin WW, Lee SS, Chen CH,. 2005. Preparation and anti-inflammatory activities of diarylheptanoid and diarylheptylamine analogs. Bioorg Med Chem 13: 6175-6181.
21. Li YJ, Bao JX, Xu JW, Murad F, Bian K,. 2010. Vascular dilation by paeonol-a mechanism study. Vascul Pharmacol 53: 169-176.
22. Lim TG, Lee SY, Huang, Z, et al,. 2014. Curcumin suppresses proliferation of colon cancer cells by targeting CDK2. Cancer Prev Res 7: 466-474.
23. + channels via cyclic nucleotide-dependent protein kinases in mesenteric artery. Phytomedicine 17: 760-770.
24. Martins CV, da Silva DL, Neres AT, et al,. 2009. Curcumin as a promising antifungal of clinical interest. J Antimicrob Chemother 63: 337-339.
25. Matsuda H, Tewtrakul S, Morikawa T, Nakamura A, Yoshikawa M,. 2004. Anti-allergic principles from Thai zedoary: structural requirements of curcuminoids for inhibition of degranulation and effect on the release of TNF-alpha and IL-4 in RBL-2H3 cells. Bioorg Med Chem 12: 5891-5898.
26. Metzler M, Pfeiffer E, Schulz SI, Dempe JS,. 2013. Curcumin uptake and metabolism. Biofactors 39: 14-20.
27. Morsy MA, El-Moselhy MA,. 2013. Mechanisms of the protective effects of curcumin against indomethacin-induced gastric ulcer in rats. Pharmacology 91: 267-274.
28. Pan MH, Huang TM, Lin JK,. 1999. Biotransformation of curcumin through reduction and glucuronidationin mice. Drug Metabol Dispos 27: 486-494.
29. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales NP,. 2007. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull 30: 74-78.
30. Srimuangwong K, Tocharus C, Yoysungnoen Chintana P, Suksamrarn A, Tocharus J,. 2012a. Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells. World J Gastroenterol 18: 2383-2389.
31. Srimuangwong K, Tocharus C, Tocharus J, Suksamrarn A, Chintana PY,. 2012b. Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats. World J Gastroenterol 18: 6951-6959.
32. Sun T, Liu R, Cao YX,. 2011. Vasorelaxant and antihypertensive effects of formononetin through endothelium-dependent and -independent mechanisms. Acta Pharmacol Sin 32: 1009-1018.
33. Tao L, Hu HS, Shen XC,. 2013. Endothelium-dependent vasodilatation effects of the essential oil from Fructus Alpiniae Zerumbet (EOFAZ) on rat thoracic aortic rings in vitro. Phytomedicine 20: 387-393.
34. Venkateswarlu S, Ramachandra MS, Subbaraju GV,. 2005. Synthesis and biological evaluation of polyhydroxycurcuminoids. Bioorg Med Chem 13: 6374-6380.
35. Xu PH, Long Y, Dai F, Liu ZL,. 2007. The relaxant effect of curcumin on porcine coronary arterial ring segments. Vascul Pharmacol 47: 25-30.
36. (2+)concentration in porcine coronary arterial smooth muscle cells. J Pharmacol Exp Ther 342: 486-496.
37. Zhang HS, Ruan Z, Sang WW,. 2011. HDAC1/NFkappaB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation. J Cell Physiol 226: 3385-3391.